Cause-specific mortality in type 2 diabetes - The Verona Diabetes Study

被引:293
作者
de Marco, R
Locatelli, F
Zoppini, G
Verlato, G
Bonora, E
Muggeo, M
机构
[1] Univ Verona, Sch Med, Div Med Stat, I-37100 Verona, Italy
[2] Univ Verona, Sch Med, Div Endocrinol & Metab Dis, I-37100 Verona, Italy
关键词
D O I
10.2337/diacare.22.5.756
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - This population-based study, carried out in the framework of the Verona Diabetes Study investigated mortality from specific causes in known type 2 diabetic patients. RESEARCH DESIGN AND METHODS - A cohort of 7,148 known type 2 diabetic patients (3,366 men and 3,782 women) was identified on 31 December 1986 and followed up for 5 years (1987-1991). Underlying causes of death were obtained from death certificates and were coded according to the International Classification of Diseases, Ninth Revision. Cause-specific death rates of diabetic subjects were compared with those of the inhabitants of Verona. By 31 December 1991, 1,550 diabetic subjects (744 men and 806 women) had died. RESULTS - The standardized mortality ratio (SMR) for all causes of death was 1.42 (9596 CI 1.35-1.50). The highest SMRs were for the following specific causes: diabetes (SMR 4.47 [3.91-5.10]), gastrointestinal diseases (1.83 [1.50-2.21])-particularly liver cirrhosis (2.52 [1.96-3.20])-and cardiovascular diseases (1.34 [1.23-1.44]), particularly cerebrovascular (1.48 [1.25-1.73]) and ischemic heart diseases (1.41 [1.24-1.62]). A significantly higher than expected risk of mortality for cardiovascular causes was already present in the first 5 years after diagnosis and decreased with age. Type 2 diabetic patients treated with insulin had a higher risk of dying than those treated orally or by diet. CONCLUSIONS - The highest SMRs in the diabetic cohort were for diabetes and liver cirrhosis. The mortality risk for cardiovascular diseases, although significantly higher than expected, was much lower in Italian type 2 diabetic patients than that reported for American patients. The evidence of an early effect on mortality suggests that prevention, early diagnosis, and treatment should be improved.
引用
收藏
页码:756 / 761
页数:6
相关论文
共 43 条
[21]  
HARRIS MJ, 1991, DIABETES CARE, V20, P446
[22]   THE TREATMENT OF HYPERTENSION IN WOMEN [J].
KAPLAN, NM .
ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (06) :563-567
[23]   MORTALITY EXPERIENCE OF DIABETIC PATIENTS - 26-YEAR FOLLOW-UP STUDY [J].
KESSLER, II .
AMERICAN JOURNAL OF MEDICINE, 1971, 51 (06) :715-&
[24]  
KESSLER II, 1970, J NATL CANCER I, V44, P673
[25]  
KINGSTON ME, 1984, GASTROENTEROLOGY, V87, P688
[26]   MORTALITY AMONG DIABETICS IN A NATIONAL SAMPLE [J].
KLEINMAN, JC ;
DONAHUE, RP ;
HARRIS, MI ;
FINUCANE, FF ;
MADANS, JH ;
BROCK, DB .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1988, 128 (02) :389-401
[27]   AN ANALYSIS OF EXCESS MORTALITY-RATES FOR PERSONS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS IN WESTERN AUSTRALIA USING THE COX PROPORTIONAL HAZARDS REGRESSION-MODEL [J].
KNUIMAN, MW ;
WELBORN, TA ;
WHITTALL, DE .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1992, 135 (06) :638-648
[28]   Diabetes, asymptomatic hyperglycemia, and 22-year mortality in black and white men - The Chicago Heart Association Detection Project in Industry study [J].
Lowe, LP ;
Liu, KA ;
Greenland, P ;
Metzger, BE ;
Dyer, AR ;
Stamler, J .
DIABETES CARE, 1997, 20 (02) :163-169
[29]   CAUSE-SPECIFIC MORTALITY IN A POPULATION-BASED STUDY OF DIABETES [J].
MOSS, SE ;
KLEIN, R ;
KLEIN, BEK .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1991, 81 (09) :1158-1162
[30]   LONG-TERM INSTABILITY OF FASTING PLASMA-GLUCOSE PREDICTS MORTALITY IN ELDERLY NIDDM PATIENTS - THE VERONA DIABETES STUDY [J].
MUGGEO, M ;
VERLATO, G ;
BONORA, E ;
CIANI, F ;
MOGHETTI, P ;
EASTMAN, R ;
CREPALDI, G ;
DEMARCO, R .
DIABETOLOGIA, 1995, 38 (06) :672-679